Litigation costs shall be borne by the plaintiff.

A. The Plaintiff, a corporation mainly engaged in manufacturing, supplying, purchasing, selling, etc. of drugs, has been selling drugs developed by the Plaintiff from the Korea Food and Drug Administration affiliated with the Defendant (hereinafter “Korea Food and Drug Administration”) with prior permission for manufacture, sale, etc.

B. At the end of March 2009, the Food and Drug Administration (KBS Consumer Complaint Program) collected 30 items from 12 items of investigation, including the 14 Vibane scam scam scam scam scam scam scam scam scam scam scam scam scam scamscamscams, and inspected them. As a result of the examination, it is confirmed that asbestos is detected in the 12 items of investigation, including the Nibam scam scam scam scamscam scamscamscams (hereinafter referred to as the "Vibam scam scam scam scam scamscamscam scamscamscamscam scamscamscamscams, etc.

In accordance with this, 12 of 8 asbestos detected, 12 of bed and distributed products, and other measures such as recall thereof were ordered.

C. Meanwhile, the Food and Drug Administration around that time.